Cytek Biosciences
CTKB
CTKB
74 hedge funds and large institutions have $515M invested in Cytek Biosciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $572M → $515M (-$57.2M)
Holders
74
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$55.4M | |
| 2 | +$40.7M | |
| 3 | +$40.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$7.74M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$23.2M | |
| 3 | -$22.5M | |
| 4 |
MGM
Miura Global Management
New York
|
-$8.25M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$6.53M |